Becton Dickinson (NYSE:BDX) beat the consensus forecast on Wall Street today with its preliminary fiscal 2019 first quarter results and confirmed its outlook for the rest of fiscal 2019. The Franklin Lakes, N.J.-based healthcare giant said it expects to post adjusted earnings per share of $2.70 on sales of $4.16 billion for the three months ended Dec. […]
Erleada is a next generation oral androgen receptor inhibitor approved to treat adult patients with nmCRPC who are at high risk of developing metastatic disease. Apalutamide holds capacity The post Janssen gets EC nod for prostate cancer drug Erleada appeared first on Pharmaceutical Business review.
The designation to SLN124 was granted by the Committee for Orphan Medicinal Products (COMP), a committee of the European Medicines Agency (EMA). COMP after reviewing an application filed The post Silence’s SLN124 gets orphan designation in Europe for β-Thalassemia appeared first on Pharmaceutical Business review.
Juvenescence intends to complete its $100 million Series B financing with the closing of a second tranche in Q1 2019. Juvenescence has now raised over $110 million in The post Juvenescence closes first tranche of series B financing for further growth and development appeared first on Pharmaceutical Business review.
This is the first time that a multinational pharmaceutical company has gained exclusive authorization in China to promote an innovative drug independently developed by a Chinese pharmaceutical company. The post Luye Pharma grants AstraZeneca exclusive rights to promote Xuezhikang Capsules in mainland China appeared first on Pharmaceutical Business review.
Henry Schein (NSDQ:HSIC) said today that it is shifting the date for the spin-out of its animal health business, now dubbed “Covetrus,” from February 4 to February 7. The change was implemented by the Melville, N.Y.-based company’s board of directors, according to company press release. The new date reflects the new anticipated date for distribution of shares […]
Integer Holdings (NYSE:ITGR), formerly known as Greatbatch, has been awarded approximately $22.2 million in damages in the retrial of a pacer tech patent spat with AVX, down from a previous award of $37.5 million, according to recently released court documents. Integer originally filed a patent infringement complaint in April 2013, alleging that AVX infringed on patents […]
Brainsway has registered for an upcoming initial public offering, looking to bring in $30 million to support its transcranial magnetic stimulation tech, according to a recently posed SEC filing. The Israel-based company said that it plans to list on the Nasdaq Global Market under the symbol “BWAY,” according to the filing. Brainsway develops and supports […]
RFPi’s iCertainty shows images of blood flow and perfusion without contact with the patient. FDA has cleared RFPi’s iCertainty real-time, noninvasive blood flow and perfusion imaging medical device for use during surgical procedures, the company said. iCertainty is the first medical imaging device to show blood flow without interrupting a surgical procedure or requiring injections, dyes, radiation or […]
Bolder Surgical, formerly known as JustRight Surgical, said today that it raised $27 million in a new round of financing to support its laparoscopic surgical devices. The round was led by River City Capital Funds and joined by Westwood Management, Providence Ventures and previous investors, the Louisville, Colo.-based company said. Funds raised in the round […]